Targeted Therapy Development in Acute Myeloid Leukemia

Therapeutic developments targeting acute myeloid leukemia (AML) have been in the pipeline for five decades and have recently resulted in the approval of multiple targeted therapies. However, there remains an unmet need for molecular treatments that can deliver long-term remissions and cure for this...

Descripción completa

Detalles Bibliográficos
Autores principales: Totiger, Tulasigeri M., Ghoshal, Anirban, Zabroski, Jenna, Sondhi, Anya, Bucha, Saanvi, Jahn, Jacob, Feng, Yangbo, Taylor, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953553/
https://www.ncbi.nlm.nih.gov/pubmed/36831175
http://dx.doi.org/10.3390/biomedicines11020641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953553/
https://www.ncbi.nlm.nih.gov/pubmed/36831175
http://dx.doi.org/10.3390/biomedicines11020641

Ejemplares similares